Characterizing the Clinical Adoption of Medical AI Devices through U.S. Insurance Claims
- DHV-NET
- Dec 1, 2023
- 1 min read
There are now over 500 medical artificial intelligence (AI) devices that are approved by the
U.S. Food and Drug Administration. However, little is known about where and how often
these devices are actually used after regulatory approval. In this article, we systematically
quantify the adoption and usage of medical AI devices in the United States by tracking Current Procedural Terminology (CPT) codes explicitly created for medical AI. CPT codes are
widely used for documenting billing and payment for medical procedures, providing a measure of device utilization across different clinical settings. We examined a comprehensive
nationwide claims database of 11 billion CPT claims between January 1, 2018, and June 1,
2023 to analyze the prevalence of medical AI devices based on submitted claims. Our
results indicate that medical AI device adoption is still nascent, with most usage driven by a
handful of leading devices. For example, only AI devices used for assessing coronary artery
disease and for diagnosing diabetic retinopathy have accumulated more than 10,000 CPT
claims. Furthermore, we found that zip codes that had a higher income level, were metropolitan, and had academic medical centers were much more likely to have medical AI
usage. Our study sheds light on the current landscape of medical AI device adoption and
usage in the United States, underscoring the need to further investigate barriers and incentives to promote equitable access and broader integration of AI technologies in health car